Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H16N4O8S |
Molecular Weight | 424.385 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C3=CC=CO3)C(O)=O
InChI
InChIKey=JFPVXVDWJQMJEE-IZRZKJBUSA-N
InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1
Molecular Formula | C16H16N4O8S |
Molecular Weight | 424.385 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:25 UTC 2023
by
admin
on
Fri Dec 15 14:59:25 UTC 2023
|
Record UNII |
O1R9FJ93ED
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ01DC02
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NCI_THESAURUS |
C357
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-VATC |
QS01AA27
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
LIVERTOX |
NBK548358
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-ATC |
J01RA03
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-ATC |
J01DC02
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
LIVERTOX |
NBK548666
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
LIVERTOX |
NBK547862
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-ATC |
S01AA27
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-VATC |
QJ01RA03
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000011161
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
WHO-VATC |
QJ51DC02
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
||
|
NDF-RT |
N0000175488
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1436
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
DTXSID5022774
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
D002444
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
U-22
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
m3226
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB01112
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
O1R9FJ93ED
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
100000092667
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
2194
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | RxNorm | ||
|
3902
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
259-560-1
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
SUB07433MIG
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
Cefuroxime
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
55268-75-2
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
565
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
C61669
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
3515
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
Cefuroxime
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
O1R9FJ93ED
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY | |||
|
5479529
Created by
admin on Fri Dec 15 14:59:25 UTC 2023 , Edited by admin on Fri Dec 15 14:59:25 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
|
||
|
EXCRETED UNCHANGED |
Metabolically stable
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||